Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Elucidating Regulatory Intracellular Mechanisms of Multimeric MAVS Aggregation and Subsequent Pathophysiological Outcomes in Myocardial Infarction
EF 2022-23
Résumé
Mitochondrial Antiviral Signalling (MAVS) is a caspase recruitment domain (CARD)-containing protein, residing uniquely on mitochondrial surfaces and is classically involved in viral innate immune signalling. MAVS has since been recognized for its noncanonical role in coordinating cardiac remodelling, mitochondrial energy metabolism and inflammatory response in stressed cardiomyocytes. MAVS aggregation is essential for propagating MAVS signalling. However, persistent over-aggregation of MAVS may lead to chronic inflammatory/autoimmune disease states – thus, highlighting the potential for negative consequences modulating from MAVS over-aggregation in myocardial infarction (MI). Since both MAVS and PINK1 reside on mitochondrial surfaces it is plausible that Parkin-mediated mitophagy plays a key role in regulating both formation and subsequent clearance of MAVS aggregates. Moreover, in pulmonary pathology, PINK1 was shown to directly inhibit MAVS aggregation and regulate innate immune overactivity during mitochondrial stress. In cardiovascular disease models however, negative regulators of MAVS aggregation remain unelucidated. PINK1’s potential direct inhibitory role, and alternative functional role in initiating Parkin mediated mitophagy, highlights PINK1’s potential for being a dual regulator of MAVS aggregation in stressed cardiomyocytes. Elucidating cardiovascular outcomes that modulate from the MAVS-PINK1 interaction represents both a means to further elucidate MAVS noncanonical function in innate cardiovascular immunity and potential therapeutic opportunity. Significant research outcomes may advance understanding of cardiac immune physiology and inform potential therapeutic interventions that optimize cardiac remodelling processes and improve post-MI prognosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486404
Name
Haggerty Teagan G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating Regulatory Intracellular Mechanisms of Multimeric MAVS Aggregation and Subsequent Pathophysiological Outcomes in Myocardial Infarction
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autophagy; Cardiac Function; Cardiac Remodeling; Inflammation And Fibrosis; Innate Immunity; Mitochondrial Antiviral-Signalling (Mavs) Protein; Mitochondrial Dysfunction; Mitophagy; Myocardial Infarction; Ubiquitin-Proteasome Systems
Abstract
Mitochondrial Antiviral Signalling (MAVS) is a caspase recruitment domain (CARD)-containing protein, residing uniquely on mitochondrial surfaces and is classically involved in viral innate immune signalling. MAVS has since been recognized for its noncanonical role in coordinating cardiac remodelling, mitochondrial energy metabolism and inflammatory response in stressed cardiomyocytes. MAVS aggregation is essential for propagating MAVS signalling. However, persistent over-aggregation of MAVS may lead to chronic inflammatory/autoimmune disease states – thus, highlighting the potential for negative consequences modulating from MAVS over-aggregation in myocardial infarction (MI). Since both MAVS and PINK1 reside on mitochondrial surfaces it is plausible that Parkin-mediated mitophagy plays a key role in regulating both formation and subsequent clearance of MAVS aggregates. Moreover, in pulmonary pathology, PINK1 was shown to directly inhibit MAVS aggregation and regulate innate immune overactivity during mitochondrial stress. In cardiovascular disease models however, negative regulators of MAVS aggregation remain unelucidated. PINK1’s potential direct inhibitory role, and alternative functional role in initiating Parkin mediated mitophagy, highlights PINK1’s potential for being a dual regulator of MAVS aggregation in stressed cardiomyocytes. Elucidating cardiovascular outcomes that modulate from the MAVS-PINK1 interaction represents both a means to further elucidate MAVS noncanonical function in innate cardiovascular immunity and potential therapeutic opportunity. Significant research outcomes may advance understanding of cardiac immune physiology and inform potential therapeutic interventions that optimize cardiac remodelling processes and improve post-MI prognosis.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Haggerty, Teagan G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~